|
시장보고서
상품코드
1789376
세계의 바이오필름 치료 시장 : 치료 방법별, 제품별, 감염증 유형별, 병원균 유형별, 최종 사용자별, 지역별(2025-2032년)Biofilm Treatment Market, By Treatment Method, By Product, By Infection Type, By Pathogen Type,By End User, By Geography |
||||||
세계의 바이오필름 치료 시장은 2025년 23억 8,000만 달러로 추정되고, 2032년까지 41억 3,000만 달러에 이를 것으로 예측되며, 예측 기간 중 연평균 성장률(CAGR) 8.20%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 23억 8,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간 CAGR(2025-2032년) | 8.20% | 예측 금액(2032년) | 41억 3,000만 달러 |
세계의 바이오필름 치료 시장은 의료 및 바이오테크놀러지 산업에서 급속히 발전하고 있는 분야이며, 현대의료에서 가장 근본적인 과제 중 하나를 다루고 있습니다. 바이오필름은 의료기기, 조직, 환경 기질 등의 표면에 부착하는 자기 생산 세포외 고분자 물질에 싸인 복잡한 미생물 군집입니다. 이러한 구조화된 미생물 군집은 전통적인 항균 치료에 현저한 내성을 나타내며, 인간에서 미생물 감염의 약 80%를 유발합니다.
의료용 임플란트, 카테터, 보철기구, 만성 상처에 바이오필름이 형성되면 치료 실패, 입원 기간 연장, 헬스케어 비용 증가 등 심각한 임상 과제가 발생합니다. 바이오필름 치료 시장은 항균제, 효소 치료, 물리적 파괴법, 바이오필름 형성의 예방 및 확립된 바이오필름 구조의 효과적인 제거를 목적으로 하는 신규 바이오테크놀러지 솔루션 등 다양한 치료 접근법을 포함합니다. 만성 질환의 유병률 증가, 의료용 임플란트의 사용 증가, 바이오필름 관련 감염에 대한 의식 증가, 항균제 내성과 싸우는 긴급한 필요성으로 이 시장은 세계 제약회사, 의료기기 제조업체, 의료 제공자로부터 큰 주목을 받고 있으며, 첨단 바이오필름 관리 솔루션에 대한 혁신과 투자를 촉진하고 있습니다.
시장 역학
세계 바이오필름 치료 시장은 강력한 성장 궤도를 뒷받침하는 몇 가지 주요 요인들에 의해 지원되고 있습니다. 주요 촉진요인은 만성 상처, 특히 당뇨병 발 궤양과 욕창의 유병률이 증가하는 것입니다. 이러한 상처는 바이오 필름 형성의 영향을 매우 받기 쉽고 치유 과정을 현저하게 억제합니다. 노인은 만성 질환에 걸리기 쉽고 이식 가능한 기구를 포함한 빈번한 의료 개입이 필요하기 때문입니다.
게다가 정형외과용 인공기관, 심장혈관용 기구, 요도 카테터 등의 의료용 임플란트의 채용이 증가하고 있으며, 이들 기구는 바이오필름 개척을 위한 모습의 표면이 되기 때문에 큰 시장 기회를 창출하고 있습니다. 바이오필름과 관련된 합병증과 치료 결과에 미치는 영향에 대한 의료 전문가의 의식이 높아짐에 따라 진단과 치료 중재가 증가하고 있습니다.
그러나, 바이오필름의 구조가 복잡하기 때문에 치료가 곤란하고, 병용 요법이 필요하게 되는 경우가 많아, 비용 상승이나 치료 기간의 장기화로 이어지는 등, 시장은 현저한 억제요인에 직면하고 있습니다. 또한 다양한 미생물군에 대한 효능을 입증하기 위해서는 대규모 임상시험이 필요하기 때문에 신규 바이오필름 치료제품에 대한 규제상의 장애물도 큰 장벽이 되고 있습니다.
많은 의료 시스템에서 고급 바이오필름 치료에 대한 상환 범위가 제한되어 시장 성장을 더욱 억제하고 있습니다. 그럼에도 불구하고 나노 기술 기반 솔루션, 광역학 요법 및 개인화된 의료 접근법과 같은 혁신적인 치료법을 개발하는 데 큰 비즈니스 기회가 있습니다. 신속한 바이오필름 검출을 위한 POC(Point of Care) 진단 도구의 출현은 유리한 전망을 제시하고, 치료 계획에서 인공지능의 통합은 시장 확대와 환자 결과 향상을 위한 유망한 길을 제공합니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 바이오필름 치료 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 출시와 승인, 시장 동향, 지역별 전망, 주요기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계 바이오필름 치료 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개변수를 기반으로 게재됩니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- '세계의 바이오필름 치료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계의 바이오필름 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 합병 및 인수(M&A) 시나리오
- 업계 동향
제4장 세계의 바이오필름 치료 시장 : 치료 방법별(2020-2032년)
- 항균제(항생제)
- 소독제
- 효소(예 : DNase, 디스퍼신 B)
- 계면활성제(음이온 계면활성제, 양이온 계면활성제)
- 파지 치료제품(박테리오파지)
- 나노입자
- 광선역학요법
- 의료기기 코팅(부착 방지 코팅 등)
제5장 세계의 바이오필름 치료 시장 : 제품별(2020-2032년)
- 괴사 조직 제거 기기
- 거즈 및 드레싱
- 항균 젤, 연고, 스프레이
- 와이프, 패드, 세정액
- 기타(이식편 및 매트릭스)
제6장 세계의 바이오필름 치료 시장 : 감염증 유형별(2020-2032년)
- 만성 상처 감염
- 임플란트 관련 감염증
- 치아 바이오 필름
- 부비동염 및 귀 감염증
- 요로 감염(UTI)
- 위장 감염증
- 호흡기 감염증
- 골수염(뼈 감염)
제7장 세계의 바이오필름 치료 시장 : 병원균 유형별(2020-2032년)
- 곰팡이 바이오 필름
- 바이러스 바이오 필름
제8장 세계의 바이오필름 치료 시장 : 최종 사용자별(2020-2032년)
- 병원
- 치과 진료소
- 바이오의약품산업
- 동물병원
- 진단실험실
- 기타(학술연구 기관 등)
제9장 세계의 바이오필름 치료 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제10장 경쟁 구도
- Smith and Nephew plc
- ConvaTec Group PLC
- Kane Biotech Inc.
- Ecolab Inc.
- Microbion Corp.
- Kane Biotech Inc.
- Nelson Laboratories, LLC
- BioSurface Technologies
- Other Prominent Players
제11장 애널리스트의 제안
- 「운명의 고리」
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제12장 참고문헌과 조사방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Biofilm Treatment Market is estimated to be valued at USD 2.38 Bn in 2025 and is expected to reach USD 4.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.20% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.38 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.20% | 2032 Value Projection: | USD 4.13 Bn |
The global biofilm treatment market represents a rapidly evolving segment within the healthcare and biotechnology industries, addressing one of the most persistent challenges in modern medicine. Biofilms are complex microbial communities encased in self-produced extracellular polymeric substances that adhere to surfaces, including medical devices, tissues, and environmental substrates. These structured microbial communities exhibit remarkable resistance to conventional antimicrobial treatments, making them responsible for approximately 80% of all microbial infections in humans.
The formation of biofilms on medical implants, catheters, prosthetic devices, and chronic wounds poses significant clinical challenges, leading to treatment failures, prolonged hospital stays, and increased healthcare costs. The biofilm treatment market encompasses various therapeutic approaches including antimicrobial agents, enzymatic treatments, physical disruption methods, and novel biotechnological solutions designed to prevent biofilm formation or effectively eliminate established biofilm structures. With the rising prevalence of chronic diseases, increasing use of medical implants, growing awareness about biofilm-related infections, and the urgent need to combat antimicrobial resistance, this market has gained substantial attention from pharmaceutical companies, medical device manufacturers, and healthcare providers worldwide, driving innovation and investment in advanced biofilm management solutions.
Market Dynamics
The global biofilm treatment market is propelled by several key drivers that collectively fuel its robust growth trajectory. The primary driver is the escalating prevalence of chronic wounds, particularly diabetic foot ulcers and pressure sores, which are highly susceptible to biofilm formation and significantly impede healing processes. The aging global population further amplifies this demand as elderly individuals are more prone to chronic conditions and require frequent medical interventions involving implantable devices.
Additionally, the increasing adoption of medical implants, including orthopedic prosthetics, cardiovascular devices, and urinary catheters, creates a substantial market opportunity as these devices serve as prime surfaces for biofilm development. The growing awareness among healthcare professionals about biofilm-related complications and their impact on treatment outcomes has led to increased diagnostic and therapeutic interventions.
However, the market faces notable restraints including the complex nature of biofilm structures that make treatment challenging and often require combination therapies, leading to higher costs and extended treatment durations. Regulatory hurdles for novel biofilm treatment products also pose significant barriers, as demonstrating efficacy against diverse microbial communities requires extensive clinical trials.
The limited reimbursement coverage for advanced biofilm treatments in many healthcare systems further constrains market growth. Nevertheless, substantial opportunities exist in the development of innovative treatment modalities such as nanotechnology-based solutions, photodynamic therapy, and personalized medicine approaches. The emergence of point-of-care diagnostic tools for rapid biofilm detection presents lucrative prospects, while the integration of artificial intelligence in treatment planning offers promising avenues for market expansion and enhanced patient outcomes.
Key Features of the Study
- This report provides in-depth analysis of the global biofilm treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global biofilm treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include leading pharmaceutical companies, medical device manufacturers, biotechnology firms, and specialized biofilm treatment solution providers.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global biofilm treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biofilm treatment market.
Market Segmentation
- Treatment Method Insights (Revenue, USD Bn, 2020 - 2032)
- Antimicrobial Agents (Antibiotics)
- Disinfectants
- Enzymes (e.g., DNase, Dispersin B)
- Surfactants (Anionic, Cationic Surfactants)
- Phage Therapy Products (Bacteriophages)
- Nanoparticles
- Photodynamic Therapy
- Medical Device Coatings (Anti-adhesive Coatings, etc.)
- Product Insights (Revenue, USD Bn, 2020 - 2032)
- Debridement Equipment
- Gauzes and Dressings
- Antimicrobial Gels, Ointments, and Sprays
- Wipes, Pads, and Lavage Solutions
- Others (Grafts and Matrices)
- Infection Type Insights (Revenue, USD Bn, 2020 - 2032)
- Chronic Wound Infections
- Implant-related Infections
- Dental Biofilms
- Sinusitis and Ear Infections
- Urinary Tract Infections (UTIs)
- Gastrointestinal Infections
- Respiratory Infections
- Osteomyelitis (Bone Infections)
- Pathogen Type Insights (Revenue, USD Bn, 2020 - 2032)
- Fungal Biofilms
- Viral Biofilms
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Dental Clinics
- Biopharmaceutical Industries
- Veterinary Hospitals
- Diagnostic Laboratories
- Others (Academic and Research Institutions, etc.)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Smith and Nephew plc
- ConvaTec Group PLC
- Kane Biotech Inc.
- Ecolab Inc.
- Microbion Corp.
- Kane Biotech Inc.
- Nelson Laboratories, LLC
- BioSurface Technologies
- Other Prominent Players
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Biofilm Treatment Market, By Treatment Method
- Global Biofilm Treatment Market, By Product
- Global Biofilm Treatment Market, By Infection Type
- Global Biofilm Treatment Market, By Pathogen Type
- Global Biofilm Treatment Market, By End User
- Global Biofilm Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Biofilm Treatment Market, By Treatment Method, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antimicrobial Agents (Antibiotics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Disinfectants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Enzymes (e.g., DNase, Dispersin B)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Surfactants (Anionic, Cationic Surfactants)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Phage Therapy Products (Bacteriophages)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nanoparticles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Photodynamic Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Device Coatings (Anti-adhesive Coatings, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Biofilm Treatment Market, By Product, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Debridement Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gauzes and Dressings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antimicrobial Gels, Ointments, and Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Wipes, Pads, and Lavage Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Grafts and Matrices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Biofilm Treatment Market, By Infection Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Chronic Wound Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Implant-related Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dental Biofilms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sinusitis and Ear Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Urinary Tract Infections (UTIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gastrointestinal Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Osteomyelitis (Bone Infections)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Biofilm Treatment Market, By Pathogen Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Fungal Biofilms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Viral Biofilms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Biofilm Treatment Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dental Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biopharmaceutical Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Academic and Research Institutions, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Biofilm Treatment Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Smith and Nephew plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ConvaTec Group PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kane Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ecolab Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Microbion Corp.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kane Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nelson Laboratories, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioSurface Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Other Prominent Players
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
